Anne Nunes - 01 Oct 2023 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role: SVP, Chief Operations Officer
Signature: /s/ Anne Nunes
Issuer symbol: ANIK
Transactions as of: 01 Oct 2023
Net transactions value: -$13,637
Form type: 4
Filing time: 03 Oct 2023, 16:31:56 UTC
Previous filing: 12 Jan 2024
Next filing: 12 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIK	Common Stock	Options Exercise	$0	+2,491	+76%	$0.000000	5,784	01 Oct 2023	Direct	F1
transaction	ANIK	Common Stock	Tax liability	$13,637	-732	-13%	$18.63	5,052	01 Oct 2023	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANIK	Restricted Stock Unit	Options Exercise	$0	-2,491	-100%	$0.000000^*	0	01 Oct 2023	Common Stock	2,491	$0.000000	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on October 1, 2021.
F2	Reflects an aggregate of 732 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on October 1, 2023.
F3	Reflects the closing price of ANIK common stock on September 29, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
F4	Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning October 1, 2022.